Login to Your Account



Chugai licenses MAb as Galderma makes foray into biologics

By Cornelia Zou
Staff Writer

Friday, July 22, 2016

HONG KONG – Japan's Chugai Pharmaceutical Co. Ltd. has licensed rights to its treatment for skin diseases to the company's Swiss partner, Galderma Pharma SA.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription